Protagonist Therapeutics (PTGX) has an average rating of buy and mean price target of $159.36, according to analysts polled by FactSet.
What else is happening in Research?
Research
Citigroup Downgrades Trade Desk to Sell From Neutral, Adjusts PT to $11 From $21
Trade Desk (TTD) has an average rating of hold and mean price target of $18.02, according to analysts polled by FactSet.Price: $13.67, Change: $-4.00, Percent Change: -22.64%
$TTD
Research
Update: BofA Securities Upgrades Atlassian to Buy From Neutral, Raises PT to $175 From $105; Notes 'Strong' Fiscal Q4 Results
(Updated to include prior price target in headline and commentary on fiscal Q4 results.)Atlassian (TEAM) has an average rating of buy and mean price target of $177.46, according to analysts polled by FactSet.Price: $148.60, Change: $+38.43, Percent Change: +34.88%
$TEAM
Research
Seaport Global Securities Downgrades Fox to Neutral From Buy
Fox (FOX) has an average rating of overweight and mean price target of $69.27, according to analysts polled by FactSet.
$FOX$FOXA